Virtus LifeSci Biotech Clinical Trials ETF - USD Stock

ETF

BBC

US26923G3011

Market Closed - Nyse 04:10:00 2024-05-31 pm EDT 5-day change 1st Jan Change
26.52 USD -0.44% Intraday chart for Virtus LifeSci Biotech Clinical Trials ETF - USD +0.48% +8.54%
1 month+1.62%
3 months-11.82%
Dynamic Chart

Investment objective

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Name
Price
Change
5d. change
1st Jan change
Weight
62.26 USD +0.78%-0.78%+234.55%3.22%
26.86 USD -0.74%-2.15%+196.80%2.29%
45.64 USD -1.55%-4.98%+63.35%2.16%
37.99 USD +2.81%+2.37%+147.01%2.16%
7.5 USD -1.45%-6.48%+83.82%1.81%
31.88 USD +2.18%+2.11%+139.70%1.74%
12.87 USD +0.08%+3.62%+6.98%1.67%
24 USD -2.60%-4.57%+18.46%1.57%
64.97 USD +0.02%-.--%+240.87%1.51%
23.5 USD +3.12%-2.61%+130.62%1.51%
See all (103)
In partnership with
TrackInsight
Date Price Change Volume
24-05-31 26.52 -0.44% 4,016
24-05-30 26.63 +3.19% 11,266
24-05-29 25.81 -2.01% 2,375
24-05-28 26.34 -0.58% 491
24-05-24 26.49 +0.39% 778

Delayed Quote Nyse

Last update May 31, 2024 at 04:10 pm EDT

More quotes

ETF Ratings

Description

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
2014-12-14
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2024-04-29 )

AuM (EUR) 10 M€
AuM 1M 11 M€
AuM 3 months 9 M€
AuM 6 months 8 M€
AuM 12 months 11 M€